Similar articles

• Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I.

  Backeljauw P. Backeljauw P. Pediatr Endocrinol Rev. 2008 Apr;5 Suppl 3:853-6. Pediatr Endocrinol Rev. 2008. PMID: 18438329 Review. No abstract available.
• Statement 1: a serum insulin-like growth factor I (IGF-I) level should be part of the evaluation of children with short stature.

  Cohen P. Cohen P. Pediatr Endocrinol Rev. 2008 Apr;5 Suppl 3:834-6. Pediatr Endocrinol Rev. 2008. PMID: 18438325 Review. No abstract available.
• Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.

  Meyer S, Ipek M, Keth A, Minnemann T, von Mach MA, Weise A, Ittner JR, Nawroth PP, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Kann PH; German KIMS Board; German KIMS Pharmacogenetics Study Group. Meyer S, et al. Growth Horm IGF Res. 2007 Aug;17(4):307-14. doi: 10.1016/j.ghir.2007.03.001. Epub 2007 Apr 25. Growth Horm IGF Res. 2007. PMID: 17462934
• Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS).

  Park P, Cohen P. Park P, et al. Growth Horm IGF Res. 2005 Jul;15 Suppl A:S13-20. doi: 10.1016/j.ghir.2005.06.011. Growth Horm IGF Res. 2005. PMID: 16039893 Review.
• Partial growth hormone insensitivity.

  Johnston LB, Savage MO. Johnston LB, et al. J Pediatr Endocrinol Metab. 1999 Apr;12 Suppl 1:251-7. J Pediatr Endocrinol Metab. 1999. PMID: 10698589 Review.